IFNG and cancer: IFN-γ is used clinically in the treatment of certain cancers and plays a role in antitumor immunomodulation by increasing the sensitivity of cancer cells to induced apoptosis and inhibiting the proliferation and survival of endothelial cells in the TME [27].